Not sure if Ion582 is cause of share price weakness.It is delivered by intrathecal injection which has some risks associated with serious infections and potential cord damage. Also presume sedation or anaesthetic needed to deliver.
Interesting to see more detail but seems complex and potentially a risk in delivering as opposed to a safe well tolerated oral medication.
- Forums
- ASX - By Stock
- NEU
- Angelman trial
NEU
neuren pharmaceuticals limited
Add to My Watchlist
10.9%
!
$13.91

Angelman trial, page-29
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$13.91 |
Change
1.370(10.9%) |
Mkt cap ! $1.730B |
Open | High | Low | Value | Volume |
$12.96 | $14.00 | $12.91 | $8.495M | 621.6K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
15 | 424 | $13.89 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$13.91 | 674 | 5 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
6 | 440 | 13.890 |
8 | 621 | 13.880 |
7 | 3030 | 13.870 |
4 | 457 | 13.860 |
5 | 1224 | 13.850 |
Price($) | Vol. | No. |
---|---|---|
13.910 | 270 | 2 |
13.920 | 1116 | 5 |
13.930 | 2154 | 5 |
13.940 | 1124 | 3 |
13.950 | 1085 | 5 |
Last trade - 11.47am 26/06/2025 (20 minute delay) ? |
Featured News
NEU (ASX) Chart |
The Watchlist
PTX
PRESCIENT THERAPEUTICS LIMITED
James McDonnell, CEO
James McDonnell
CEO
Previous Video
Next Video
SPONSORED BY The Market Online